Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.

Kanervo, Minna M; Tupola, Sarimari J; Nikkola, Eeva M; Rantakari, Krista M; Kahila, Hanna K

Kanervo, Minna M; Tupola, Sarimari J; Nikkola, Eeva M; Rantakari, Krista M; Kahila, Hanna K.

Affiliation

Kanervo MM; Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Tupola SJ; Doctoral Program in Clinical Research, University of Helsinki, Helsinki, Finland.
Nikkola EM; Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Rantakari KM; Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Kahila HK; Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Acta Obstet Gynecol Scand ; 102(3): 313-322, 2023 03.

Article de En | MEDLINE | ID: mdl-36562462

Sujet(s)
Mots clés

buprenorphine; buprenorphine-naloxone; maternal opioid use disorder; methadone; neonatal opioid withdrawal syndrome; opioid maintenance treatment; pregnancy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Complications de la grossesse / Buprénorphine / Substances illicites / Troubles liés aux opiacés Type d'étude: Guideline Limites: Female / Humans / Newborn / Pregnancy Langue: En Journal: Acta Obstet Gynecol Scand Année: 2023 Type de document: Article Pays d'affiliation: Finlande Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google